BioSpring
 | |
| Website | https://www.biospring.net |
|---|---|
BioSpring GmbH is a contract manufacturing organization (CDMO) for the biotechnology and pharmaceutical industries based in Frankfurt.
History
[edit]
BioSpring was founded in 1997 by Hüseyin Aygün and Sylvia Wojczewski, then doctoral students at the University of Frankfurt. The headquarters and production facility are located in Frankfurt-Fechenheim, and the company remains owner-managed and independent. Since January 2022, BioSpring has been expanding into the neighboring city of Offenbach am Main, where new production facilities are being built.[1][2]
Production
[edit]The active ingredients produced by BioSpring offer approaches for the treatment of previously incurable diseases, including cardiovascular diseases, neurodegenerative diseases, and cancer.[3][4][5]
Nucleic acid drugs manufactured by BioSpring
[edit]- Antisense oligonucleotides (ASOs)
- Small interfering RNA (siRNA)
References
[edit]- ^ "Expansion in Offenbach: 30.000 weitere Quadratmeter für Bio-Spring" (in German). 2022-12-17. Retrieved 2025-01-13.
- ^ "Biotech-Shootingstar Biospring expandiert in Offenbach" (in German). 2022-12-16. Retrieved 2025-01-13.
- ^ "BioSpring hosts event on "Genome Editing – Medicine of the Future" in Frankfurt". Retrieved 2025-01-13.
- ^ "Am Puls der medizinischen Revolution" (in German). 2024-02-09. Retrieved 2025-01-13.
- ^ "BioSpring and Pantherna agree on strategic cooperation in the field of genome editing". Retrieved 2025-01-13.